{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:15:37Z","timestamp":1783487737762,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.4158\/ep-2018-0480","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T13:10:31Z","timestamp":1553605831000},"page":"211-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sympathetic Paraganglioma: A Single-Center Experience from Western India"],"prefix":"10.1016","volume":"25","author":[{"given":"Sanjeet Kumar","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vija ya","family":"Sarathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba Samad","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath","family":"Goroshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha y.","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag R.","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0480_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/hed.1040","article-title":"Sympathetic paraganglioma as an unusual cause of Horner's syndrome","volume":"23","author":"Moyer","year":"2001","journal-title":"Head Neck"},{"key":"10.4158\/EP-2018-0480_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0480_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Pillai","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.4158\/EP-2018-0480_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.4158\/EP-2018-0480_bb0030","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"Clinical manifestations of paraganglioma syndromes types 1\u20135","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP-2018-0480_bb0035","first-page":"147","article-title":"World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs","author":"DeLellis","year":"2004","journal-title":"Fr IARC Press"},{"key":"10.4158\/EP-2018-0480_bb0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1754-9485.12620","article-title":"Genetic status determines 18F-FDG uptake in pheochromocytoma\/paraganglioma","volume":"61","author":"Tiwari","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.4158\/EP-2018-0480_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-09-0384","article-title":"Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma","volume":"161","author":"Kopetschke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0480_bb0050","article-title":"A \u2018giant\u2019 paraganglioma in the testis","volume":"2014","author":"Makris","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.4158\/EP-2018-0480_bb0055","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.urology.2017.04.014","article-title":"Raynaud's phenomenon: revisiting a rare sign of pheochromocytoma and paraganglioma","volume":"106","author":"Patil","year":"2017","journal-title":"Urology"},{"key":"10.4158\/EP-2018-0480_bb0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.11.6.385","article-title":"Bowel perforation as a presenting feature of pheochromocytoma: case report and literature review","volume":"11","author":"Karri","year":"2005","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0480_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-15-0456","article-title":"Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma","volume":"173","author":"Thosani","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0480_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP-2018-0480_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-17-0074","article-title":"The phenotype of SDHB germline mutation carriers; a nationwide study","volume":"177","author":"Niemeijer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0480_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4158\/EP161377.OR","article-title":"Growth rate of paragangliomas related to germline mutations of the SDHX genes","volume":"23","author":"Micha\u0142owska","year":"2017","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0480_bb0085","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1210\/jcem.86.11.8034","article-title":"Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients","volume":"86","author":"Erickson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0480_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-16-0126","article-title":"Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma","volume":"175","author":"Pandit","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0480_bb0095","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0480_bb0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-14-523","article-title":"The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study","volume":"14","author":"Schovanek","year":"2014","journal-title":"BMC Cancer"},{"key":"10.4158\/EP-2018-0480_bb0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9260(97)80252-8","article-title":"MR differentiation of pheochromocytoma from other adrenal lesion based on qualitative analysis of T2 relaxation times","volume":"52","author":"Varghese","year":"1997","journal-title":"Clin Radiol"},{"key":"10.4158\/EP-2018-0480_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-017-0998-8","article-title":"MR imaging features of being retroperitoneal paragangliomas and schwannomas","volume":"18","author":"Shen","year":"2018","journal-title":"BMC Neurol"},{"key":"10.4158\/EP-2018-0480_bb0115","first-page":"350","article-title":"Images of pheochromocytoma in adrenal glands","volume":"4","author":"McDermott","year":"2015","journal-title":"Gland Surg"},{"key":"10.4158\/EP-2018-0480_bb0120","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0480_bb0125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.4158\/EP-2018-0480_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13139-015-0331-7","article-title":"Diagnostic Performance of 68Ga-DOTATATE PET\/CT, 18F-FDG PET\/CT and 131I-MIBG scintigraphy in mapping metastatic pheochromocytoma and paraganglioma","volume":"49","author":"Tan","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.4158\/EP-2018-0480_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/ERC-07-0217","article-title":"Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations","volume":"15","author":"Zelinka","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP-2018-0480_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EC-16-0086","article-title":"Predictors of malignancy in patients with pheochromocytomas\/paragangliomas: Asian Indian experience","volume":"5","author":"Khadilkar","year":"2016","journal-title":"Endocr Connect"},{"key":"10.4158\/EP-2018-0480_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5005\/jp-journals-10002-1057","article-title":"Abdominal paragangliomas: analysis of surgeon's experience","volume":"3","author":"FitzGerald","year":"2011","journal-title":"World J Endocr Surg"},{"key":"10.4158\/EP-2018-0480_bb0150","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2012-4231","article-title":"Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma","volume":"98","author":"Ayala-Ramirez","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:01Z","timestamp":1761516361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1530891X20358900"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0480","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sympathetic Paraganglioma: A Single-Center Experience from Western India","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}